NASDAQ:LBPH Longboard Pharmaceuticals (LBPH) News Today $4.80 -0.10 (-2.04%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$4.72▼$5.0950-Day Range$4.80▼$7.4952-Week Range$2.70▼$10.29Volume47,228 shsAverage Volume78,242 shsMarket Capitalization$110.30 millionP/E RatioN/ADividend YieldN/APrice Target$17.40 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Down 10.1% in Septemberamericanbankingnews.com - October 3 at 2:58 AMLongboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023finance.yahoo.com - September 19 at 2:36 PMLongboard Pharmaceuticals to Participate in Three Upcoming Investor Conferencesfinance.yahoo.com - August 31 at 7:01 PMLongboard Pharmaceuticals to Present Data at Upcoming Medical Meetingsfinance.yahoo.com - August 30 at 4:54 PMLongboard Pharmaceuticals concludes subject enrolment in study of LP352msn.com - August 24 at 4:11 PMLongboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathiesfinance.yahoo.com - August 23 at 6:39 PMInstitutional investors own a significant stake of 39% in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)finance.yahoo.com - August 10 at 10:00 AMB. Riley Equities Analysts Cut Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)marketbeat.com - August 10 at 8:31 AMH.C. Wainwright Keeps Their Buy Rating on Longboard Pharmaceuticals (LBPH)markets.businessinsider.com - August 8 at 10:34 AMLongboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 6:20 PMLongboard Pharmaceuticals to Present at Upcoming Investor Conferencesfinance.yahoo.com - August 3 at 1:18 PMHC Wainwright & Co. Reiterates Buy on Longboard Pharmaceuticals, Maintains $25 Price Targetbenzinga.com - July 11 at 7:40 AMH.C. Wainwright Reaffirms Their Buy Rating on Longboard Pharmaceuticals (LBPH)markets.businessinsider.com - July 10 at 3:38 PMLongboard Pharmaceuticals Inc.wsj.com - July 8 at 9:16 AMCantor Fitzgerald Reiterates Longboard Pharmaceuticals (LBPH) Overweight Recommendationmsn.com - June 27 at 3:29 PMLongboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023finance.yahoo.com - June 26 at 8:50 PMHC Wainwright & Co. Reiterates Longboard Pharmaceuticals (LBPH) Buy Recommendationmsn.com - May 13 at 4:03 AMWedbush Analysts Increase Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)marketbeat.com - May 12 at 8:52 AMAnalysts Offer Insights on Services Companies: Longboard Pharmaceuticals (LBPH) and New York Times (NYT)markets.businessinsider.com - May 12 at 7:59 AMWill Longboard Pharmaceuticals (NASDAQ:LBPH) Spend Its Cash Wisely?finance.yahoo.com - May 12 at 7:59 AMCantor Fitzgerald Maintains Longboard Pharmaceuticals (LBPH) Overweight Recommendationmsn.com - May 12 at 2:59 AMWedbush Reiterates Longboard Pharmaceuticals (LBPH) Outperform Recommendationmsn.com - May 11 at 9:58 PMThe Latest Analyst Ratings for Longboard Pharmaceuticalsmarkets.businessinsider.com - May 10 at 8:51 PMWedbush Reaffirms Their Buy Rating on Longboard Pharmaceuticals (LBPH)markets.businessinsider.com - May 10 at 3:50 PMRecap: Longboard Pharmaceuticals Q1 Earningsmsn.com - May 9 at 8:16 PMLongboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 9 at 8:16 PMLongboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainablefinance.yahoo.com - May 1 at 12:47 PMB. Riley Securities Initiates Coverage of Longboard Pharmaceuticals (LBPH) with Buy Recommendationmsn.com - April 28 at 12:18 AMRecent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Whyfinance.yahoo.com - April 14 at 2:57 PMLongboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 11 at 4:29 PMDoes Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect?finance.yahoo.com - April 7 at 12:53 PMSocietal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352finance.yahoo.com - April 5 at 7:58 AMHC Wainwright Research Analysts Decrease Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)marketbeat.com - March 17 at 6:05 AMAnalysts Offer Insights on Services Companies: Longboard Pharmaceuticals (LBPH) and Thoughtworks Holding (TWKS)markets.businessinsider.com - March 15 at 10:04 AMCitigroup Maintains Buy Rating for Longboard Pharmaceuticals: Here's What You Need To Knowmsn.com - March 9 at 6:55 PMWall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Knowfinance.yahoo.com - March 7 at 1:59 PMWall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Knowfinance.yahoo.com - March 7 at 1:59 PMAnalysts Offer Insights on Services Companies: Shift4 Payments (FOUR) and Longboard Pharmaceuticals (LBPH)markets.businessinsider.com - March 6 at 4:22 PMLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 6 at 11:21 AMLongboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiativesfinance.yahoo.com - March 2 at 8:26 PMEarnings Preview: Longboard Pharmaceuticalsmsn.com - March 1 at 3:11 PMLongboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023finance.yahoo.com - February 23 at 6:56 PMLongboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stockfinance.yahoo.com - February 10 at 8:56 PMLongboard Pharmaceuticals Announces Pricing of Public Offering of Common Stockfinance.yahoo.com - February 7 at 10:54 PMLongboard Pharma launches $20M stock offeringmsn.com - February 7 at 5:54 PMLongboard Pharmaceuticals Announces Commencement of Public Offering of Common Stockfinance.yahoo.com - February 7 at 5:54 PMFY2023 EPS Estimates for Longboard Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:LBPH)marketbeat.com - January 23 at 1:44 AMHedge funds investors have a lot riding on Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) with 27% ownershipfinance.yahoo.com - January 14 at 10:15 AMSkateboards, Longboards, Electric Boards - What's the Difference? Experts Explainfinance.yahoo.com - January 12 at 10:03 AMmarketbeat.com - January 4 at 10:30 AM Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address LBPH Media Mentions By Week LBPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBPH News Sentiment▼1.290.70▲Average Medical News Sentiment LBPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBPH Articles This Week▼21▲LBPH Articles Average Week Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AADI News Today PBYI News Today IFRX News Today BIVI News Today ANNX News Today XBIT News Today ALT News Today DBTX News Today SBTX News Today DSGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:LBPH) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.